Expanding expression of the 5-lipoxygenase/leukotriene B4 pathway in atherosclerotic lesions of diabetic patients promotes plaque instability
Authors:
- 9 November 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 363 (1) , 30-36
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Expression of 5-lipoxygenase and leukotriene A 4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instabilityProceedings of the National Academy of Sciences, 2006
- Association Between 5-Lipoxygenase Expression and Plaque Instability in HumansArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Inhibition of Atherogenesis in BLT1-Deficient Mice Reveals a Role for LTB4 and BLT1 in Smooth Muscle Cell RecruitmentCirculation, 2005
- Leukotriene B4Strongly Increases Monocyte Chemoattractant Protein-1 in Human MonocytesArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Lipid Inflammatory Mediators in Diabetic Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- 5-Lipoxygenase and atherosclerosisCurrent Opinion in Lipidology, 2003
- Identification of 5-Lipoxygenase as a Major Gene Contributing to Atherosclerosis Susceptibility in MiceCirculation Research, 2002
- Enhanced Expression of Vascular Matrix Metalloproteinases Induced In Vitro by Cytokines and in Regions of Human Atherosclerotic LesionsaAnnals of the New York Academy of Sciences, 1994
- North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress.Stroke, 1991
- Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and InflammationScience, 1983